The quantified self: Does personalised monitoring change everything?
Using IT to Improve Warfarin Management in the Hutt Valley
1. Using IT to Improve
Warfarin Management
in the Hutt Valley
Dr Garry Brown (Clinical Director) &
Richard Kelly (IT Specialist)
www.kowhaihealth.org.nz
Friday, 16th March 2007
In a nutshell…
..................................................................
• Warfarin is one of the 5 highest risk drugs in
clinical use
• Management of warfarin is highly complex
Significant sources of avoidable error arise from
– information flow issues from secondary to
primary care
– practice system issues
– patient compliance issues
• Use the power of IT, and the principles of the
Primary Health Care Strategy to improve
system wide management of warfarin patients
1
2. Primary Health Care Strategy
..................................................................
• Co-ordinate care across service areas
• Offer access to comprehensive services
• Continuously improve quality using good
information
• Identify and remove inequalities
• Develop the primary care workforce
• Work with local communities
Warfarin is a High Risk Drug
..................................................................
2
3. Warfarin is a High Risk Drug
..................................................................
• Levels measured by International
Normalised Ratio (INR)
• Levels too low lead to excess blood
clotting eg embolic stroke, DVT
• Levels too high lead to excess bleeding
problems eg haemorrhagic stroke, GI
bleeding
Maintenance Therapy
Risk of Intracranial Hemorrhage in Outpatients
Adapted from: Hylek EM, Singer DE, Ann Int Med 1994;120:897
-902
Hylek, et al, studied the risk of intracranial hemorrhage in out patients treated with warfarin.
They determined that an intensity of anticoagulation expressed as a p rothrombin time ratio
(PTR) above 2.0 (roughly corresponding to an INR of 3.7 to 4.3) resulted in an increase
in the risk of bleeding.
3
4. Lowest Effective Intensity for Warfarin Therapy for
Maintenance Therapy
Stroke Prevention in Atrial Fibrillation
INR below 2.0 results in a higher risk of stroke
Hylek EM, et al. NEJM 1996;335:540
-546.
-546.
Whose problem is it?
..................................................................
.
4
5. The Solution
..................................................................
The Solution
..................................................................
• Address information flow issues via
Concerto, Healthlink
• Address practice system issues using
MedTech template, and additional education
and knowledge resources
• Address patient compliance issues using
Patient Defaulters database from Aotea
Pathology
5
9. The Solution
..................................................................
• Sample of
fax sent
to Practices
with details
of their
defaulting
patients
Results
..................................................................
• Reduction in patients defaulting for INR
testing from 8.3 % down to <3% of all
patients (1200 in Hutt Valley area)
• Reliable, accurate, complete, and timely
flow of critical clinical information from
hospital to primary care
• Improved practice systems using
MedTech templates
9
10. The Future
..................................................................
• Dealing with patients who have no GP
• Can we extend this systems approach
for other high risk drugs eg: amiodarone
> a pilot is in progress
• Text/email patient INR test reminders
• Linking to Point of Care testing
• Using Web hosted decision support tools
> in development by BPAC
10